Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.79% | 171.56 | 1.2% | $575.26m | |
| CELG | Celgene Corporation | -0.75% | 88.95 | 1.2% | $554.24m | |
| GILD | Gilead Sciences, Inc. | -0.99% | 73.70 | 0.9% | $441.10m | |
| BIIB | Biogen Inc. | -1.13% | 263.02 | 1.2% | $436.72m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.50% | 314.25 | 2.7% | $242.24m | |
| INCY | Incyte Corporation | -0.90% | 68.43 | 2.5% | $236.48m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.88% | 158.15 | 1.9% | $224.32m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -3.54% | 107.78 | 2.0% | $215.70m | |
| NKTR | Nektar Therapeutics | -4.37% | 86.21 | 6.0% | $196.49m | |
| ILMN | Illumina, Inc. | -0.50% | 244.60 | 3.5% | $185.23m | |
| A | Agilent Technologies, Inc. | -0.63% | 67.54 | 1.5% | $152.87m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 1.34% | 97.48 | 9.8% | $137.98m | |
| BLUE | Bluebird Bio, Inc. | 0.00% | 170.50 | 15.8% | $135.45m | |
| EXAS | Exact Sciences Corporation | 1.54% | 47.52 | 25.7% | $108.85m | |
| BMRN | BioMarin Pharmaceutical Inc. | -1.58% | 82.30 | 4.4% | $107.66m |
Company Profile
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel medicines using its expertise in RNA biology. The company's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders and oncology. It is focused on developing treatments to fundamentally change the lives of patients living with rare genetic disorders. The company was founded by Allan S. Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.